11/21
05:49 am
rhhby
Atlas of cells offers a milestone leap in understanding of the human body [CNN]
Low
Report
Atlas of cells offers a milestone leap in understanding of the human body [CNN]
11/19
02:15 pm
rhhby
Nykode Therapeutics And 2 More Penny Stocks Worth Watching [Yahoo! Finance]
Low
Report
Nykode Therapeutics And 2 More Penny Stocks Worth Watching [Yahoo! Finance]
11/19
07:34 am
rhhby
Neuron23 Announces Usage of Roche's Digital Biomarker and Device in Parkinson's Disease Clinical Trial [Yahoo! Finance]
Low
Report
Neuron23 Announces Usage of Roche's Digital Biomarker and Device in Parkinson's Disease Clinical Trial [Yahoo! Finance]
11/18
01:04 am
rhhby
Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE [Yahoo! Finance]
Low
Report
Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE [Yahoo! Finance]
11/14
09:32 am
rhhby
Flatiron Health announces research to be presented at American Society of Hematology Annual Meeting and Exposition [Yahoo! Finance]
Low
Report
Flatiron Health announces research to be presented at American Society of Hematology Annual Meeting and Exposition [Yahoo! Finance]
11/14
07:09 am
rhhby
Hinge Bio Presents Preclinical Data from its GEM-DIMER™ Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024 [Yahoo! Finance]
Low
Report
Hinge Bio Presents Preclinical Data from its GEM-DIMER™ Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024 [Yahoo! Finance]
11/12
04:24 pm
rhhby
Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
07:00 am
rhhby
Flare Therapeutics Announces Strategic Discovery Collaboration with Roche to Address Previously Undrugged Transcription Factor Targets in Oncology
Low
Report
Flare Therapeutics Announces Strategic Discovery Collaboration with Roche to Address Previously Undrugged Transcription Factor Targets in Oncology
11/11
04:42 pm
rhhby
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib) [Yahoo! Finance]
Low
Report
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib) [Yahoo! Finance]
11/11
02:39 am
rhhby
The three-year shareholder returns and company earnings persist lower as Roche Holding (VTX:ROG) stock falls a further 3.7% in past week [Yahoo! Finance]
Low
Report
The three-year shareholder returns and company earnings persist lower as Roche Holding (VTX:ROG) stock falls a further 3.7% in past week [Yahoo! Finance]
11/11
02:16 am
rhhby
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases [Yahoo! Finance]
Low
Report
Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases [Yahoo! Finance]
11/8
02:48 am
rhhby
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... [Yahoo! Finance]
11/5
09:17 am
rhhby
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024 [Yahoo! Finance]
Low
Report
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024 [Yahoo! Finance]
11/5
09:15 am
rhhby
Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024
Low
Report
Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024
10/31
02:22 am
rhhby
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer's disease [Yahoo! Finance]
Low
Report
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer's disease [Yahoo! Finance]
10/30
05:05 pm
rhhby
New England Journal of Medicine Publishes Landmark Phase III Results for Genentech’s Itovebi, Showing More Than Doubling of Progression-Free Survival in Certain Type of HR-Positive Advanced Breast Cancer
Low
Report
New England Journal of Medicine Publishes Landmark Phase III Results for Genentech’s Itovebi, Showing More Than Doubling of Progression-Free Survival in Certain Type of HR-Positive Advanced Breast Cancer
10/29
11:01 am
rhhby
Neuvivo Expands Board of Directors in Preparation of Upcoming NDA Review with the Appointment of Robert Baffi, PhD, MBA [Yahoo! Finance]
Low
Report
Neuvivo Expands Board of Directors in Preparation of Upcoming NDA Review with the Appointment of Robert Baffi, PhD, MBA [Yahoo! Finance]
10/25
04:55 pm
rhhby
Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Chugai Pharmaceutical Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
10/25
04:37 pm
rhhby
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript [Seeking Alpha]
10/25
11:12 am
rhhby
Dyno and Roche collaborate on neurological gene therapies [Yahoo! Finance]
Low
Report
Dyno and Roche collaborate on neurological gene therapies [Yahoo! Finance]
10/25
08:30 am
rhhby
Chugai Pharmaceutical reports 9M results [Seeking Alpha]
Low
Report
Chugai Pharmaceutical reports 9M results [Seeking Alpha]
10/23
02:21 pm
rhhby
Roche Holding AG (RHHBY) Q3 2024 Sales/Trading Statement Call [Seeking Alpha]
Low
Report
Roche Holding AG (RHHBY) Q3 2024 Sales/Trading Statement Call [Seeking Alpha]
10/20
07:30 am
rhhby
Roche receives FDA approval for Ventana CLDN18 RxDx Assay [Yahoo! Finance]
Low
Report
Roche receives FDA approval for Ventana CLDN18 RxDx Assay [Yahoo! Finance]
10/18
05:00 pm
rhhby
Genentech’s Vabysmo Improved Vision in Underrepresented Populations With Diabetic Macular Edema (DME) in a First-Of-Its-Kind Study
Low
Report
Genentech’s Vabysmo Improved Vision in Underrepresented Populations With Diabetic Macular Edema (DME) in a First-Of-Its-Kind Study
10/18
02:15 pm
rhhby
Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY [Yahoo! Finance]
Low
Report
Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY [Yahoo! Finance]